Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Ono Pharmaceutical Transfers Clinical Trial Division to U.S.

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Beginning May 1, Ono Pharmaceuticals will transfer its division for coordination of clinical studies in Japan, the U.S. and Europe, to its Lawrenceville, New Jersey wholly-owned subsidiary. Ono's division for promotion of tie-ups with venture businesses and universities will also move to Ono Pharma USA, the Osaka, Japan-based company announced April 21. The reorganization is aimed at facilitating the company's approval for new drugs in the U.S., and upgrading collaboration on clinical studies in its three key markets. Company public relations head Kinya Morimoto told PharmAsia News Ono has been planning for a number of years to launch the approval process for its drugs in the three markets from the U.S. "We have relaunched Ono Pharma USA as our base for global development," Morimoto said. The approval process lag time in Japan did not factor in Ono's decision to move. Rather, the company has set as first priority doing clinical studies and getting approval for drugs in buyer countries, Morimoto explained. "As our development project unfolds, we plan to shift personnel to the U.S.," he said

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts